The Restless Leg Syndrome(RLS) induced by aripiprazole is very unique albeit rare adverse effect 1,2 .
during this period. Depressive symptoms of the patient remitted and treatment have been proceeding for one year.
In our case, the symptoms have been considered as a result of aripiprazole administration due to occurrence of the symptoms after the initiation of aripiprazole treatment, recovery of the symptoms after cessation of aripiprazole, absence of and organic disease causing RLS, normal lab results, and lack of similar picture in patient's history. The patient has been using venlafaxine and quetiapine for one year and no RLS symptoms were reported since then. Although the onset venlafaxine and quetiapine medication was proceeding, RLS symptoms were not observed after cessation of aripiprazole. In literature, a case of RLS related with the combination of venlafaxine and quetiapine was reported 3 . RLS symptoms were remitted when aripiprazole was added to treatment 4, 5 . The inflammation of the RLS by D2 receptor antagonists and well response of the symptoms to dopaminergic drugs such as levodopa, suggest that the dopaminergic system acts as central role 1 . Both improvement and causation of the RLS symptoms by aripiprazole can be explained by the partial agonistic effect on D2
receptors.
RLS may cause depression or anxiety as well as sleeping disorder and affect the quality of life.
Considering this reported side effect, especially in patients who was administered antipscyhotics, would be important for treatment follow-up and early diagnosis and treatment compliance in case this adverse effect is ensued.
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Autoimmune Psychosis: Caveats in the Diagnosis
To the Editor, I have read the review on "Autoantibodies to neurotransmitter receptors and ion channels in psychotic disorders", with interest1. The author made a commendable attempt to review the literature linking autoimmune system and psychosis. As the author pointed out, the discovery of autoantibodies specific for the neuronal cell membrane surface or synaptic proteins has yielded in paradigm shifts in diagnostic and treatment approaches to some neuropsychiatric disorders 1 In conclusion, specific clinical features with serum and/or CSF positivity for specific antibodies and a response to immunotherapy could be the best diagnostic criteria at the moment. As the author pointed out, there is an urgent need for validated diagnostic criteria and biomarkers for autoimmune psychosis 1 .
Acute Urinary Retention Related with Sublingual Buprenorphine Administration
To the Editor, Suboxone, a sublingual tablet consisting of buprenorphine/naloxone is an effective and welltolerated treatment option in the opioid dependence 1 .
Rate of urinary retention with buprenorphine is less than 1%, particularly with intrathecal and epidural delivery 2 .
However, it is rare with sublingual administration.
We decided to write this report after our observation 
